DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» SRX246
SRX246
Program Book
Novel Targets for Huntington's Disease
The Structure and Function of V1b Vasopressin Receptor
ACNP 58Th Annual Meeting: Poster Session III
Irritability in Huntington's Disease
2021.02.09.430516.Full.Pdf
Novel Pharmacological Targets in Drug Development for the Treatment of Anxiety and Anxiety-Related Disorders
Replicative Genetic Association Study Between Functional Polymorphisms
Mental Health Revolution
Translating Molecular and Neuroendocrine Findings in PTSD and Resilience to Novel Therapies
Bioactive Compound Library Plus (96-Well)
Mental Illnesses
Drug Repurposing Compound Library Plus (96-Well)
Development of a Triazolobenzodiazepine-Based PET Probe for Subtype-Selective Vasopressin 1A Receptor Imaging
Limbic Neuropeptidergic Modulators of Emotion and Their Therapeutic Potential for Anxiety and Post-Traumatic Stress Disorder
Abstract Book ASCP Annual Meeting FAIRMONT SCOTTSDALE PRINCESS MAY 30-JUNE 3, 2016
Psychiatry Update Book
(51) International Patent Classification: C07D 223/06 (2006.01) A61K 31
Top View
Drug Repurposing Compound Library (96-Well)
A Novel V1a Receptor Antagonist Blocks Vasopressin-Induced Changes in the CNS Response to Emotional Stimuli: an Fmri Study
The La Tarde Dine Hii Na Kuwa Na Matatu
Evaluating the Therapeutic Potential of the Oxytocin and Vasopressin